Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CineDoxo: Kinetics of Distribution of Doxorubicin in c-TACE
NCT03706157Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Nov 2018
- Primary completion
- Oct 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of doxorubicin in hepatocellular carcinoma (HCC), sponsored by Strasbourg University Hospital. Started Nov 2018; status: completed.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03706157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03706157.